Sawaki, A., Yamada, Y., Komatsu, Y., Kanda, T., Doi, T., Koseki, M., . . . Nishida, T. (2009). Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate. Springer-Verlag.
Chicago Style citaatSawaki, Akira, et al. Phase II Study of Motesanib in Japanese Patients With Advanced Gastrointestinal Stromal Tumors With Prior Exposure to Imatinib Mesylate. Springer-Verlag, 2009.
MLA citatieSawaki, Akira, et al. Phase II Study of Motesanib in Japanese Patients With Advanced Gastrointestinal Stromal Tumors With Prior Exposure to Imatinib Mesylate. Springer-Verlag, 2009.
Let op: Deze citaties zijn niet altijd 100% accuraat.